GLASS Classification for Infrainguinal Arterial Disease
Grades anatomic complexity of femoropopliteal and infrapopliteal arterial disease to predict revascularization outcomes
- Highest activation tier
- Recommended
- How it is scored
- Scored in code; a stated value is compared only from the structured summary or a supplied value
- Scoring type
- classification
- Care settings
- Inpatient, Outpatient
When it activates
Scribeable activates a calculator from the encounter. The GLASS Classification for Infrainguinal Arterial Disease can activate when the transcript or pasted chart context documents any of these:
- Peripheral arterial disease classification
- Infrainguinal revascularization planning
- CLTI anatomic assessment
- Femoropopliteal disease grading
- Infrapopliteal disease grading
A coded diagnosis can also activate it. ICD-10 prefixes carried by the registry: I70.2, I73.9.
Inputs the note needs
2 inputs. Each is resolved from the transcript, the pasted chart context and charted labs; at this calculator’s tier a missing input is never requested, and a missing required input keeps the score out of the draft.
| Input | Type | Unit / options | Guidance |
|---|---|---|---|
| Femoropopliteal (FP) disease grade (1-3): based on lesion length, CTO status, and anatomic pattern | exam | ||
| Infrapopliteal (IP) disease grade (1-3): based on number of diseased vessels, lesion length, and tibiopedal arterial continuity | exam |
Scoring
Femoropopliteal (FP) Grade: 1=mild (short focal stenosis/occlusion), 2=intermediate (longer lesions, moderate complexity), 3=severe (long CTO, heavily calcified, diffuse disease). Infrapopliteal (IP) Grade: 1=mild (limited disease, good runoff), 2=intermediate (moderate disease, some runoff compromise), 3=severe (extensive multivessel disease, poor runoff). Combined grading determines estimated limb-based patency (ELLA) stage.
Interpretation
FP1/IP1: Low complexity — good outcomes with endovascular or surgical revascularization. FP2/IP2: Intermediate — outcomes depend on technique selection and operator experience. FP3/IP3: High complexity — lower patency rates, higher reintervention rates, may favor bypass over endovascular in suitable candidates. Combined with clinical staging (Rutherford/WIfI) for complete CLTI management planning. GLASS predicts technical success and patency — complement with wound, ischemia, and foot infection staging for amputation risk. Integrates with GVG (Global Vascular Guidelines) framework for CLTI.
Evidence
Sources carried in Scribeable's citation registry for this calculator; guideline version: Conte 2019.
- Conte MS et al. Global Vascular Guidelines on the management of chronic limb-threatening ischemia (GVG/GLASS)Conte et al. (GLASS) 2019 · 2019 · SVS/ESVS/WFVS · Consensus · link last verified 2026-03-28
How Scribeable handles it in the note
When an encounter activates the GLASS Classification for Infrainguinal Arterial Disease (its highest tier is recommended), Scribeable does not ask you for missing inputs. The score is computed in code from whatever inputs resolve from the transcript, the pasted chart context or charted labs; a computed value is written into the draft only when every required input already resolves.
The score is computed in code from the resolved inputs, not recalled by the language model. A stated GLASS Classification for Infrainguinal Arterial Disease value is compared against the computed one when the draft's structured summary carries it; a disagreement found there is flagged to the second drafting pass, which is instructed to correct the score and its interpretation, unless Scribeable has supplied the computed value to that pass, in which case the value the draft writes is checked against the supplied one and a detected difference is shown beside the note for you to adjudicate rather than silently rewritten.
Classified as a staging or classification system: activated strictly, because a wrong stage on the wrong patient is a documentation hazard.
See it activate on your own encounter
14 days of full Pro. No sales call.
14-day Pro trial with a card on file. $79/month starts 14 days after your trial begins unless you cancel first. Cancel any time from Settings > Billing.